Literature DB >> 27769608

Variability in Outcome Reporting for Operatively Managed Anterior Glenohumeral Instability: A Systematic Review.

Jayd Lukenchuk1, Laura A Sims2, Jason J Shin3.   

Abstract

PURPOSE: The purpose of this study was to quantify the degree of variability in outcomes assessed after surgery for anterior shoulder instability in recent high-impact literature.
METHODS: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, an extensive review of the literature during a 5-year period from January 2011 through December 2015 was performed across 6 orthopaedic journals with high impact factors to identify all studies investigating outcomes after anterior shoulder instability. Studies reporting clinical outcomes for patients with anterior glenohumeral instability after surgical treatment with at least 1-year follow-up were included. Several metrics were collected from each manuscript: (1) range of motion (ROM), (2) quantitative strength, (3) physical examination testing, (4) imaging, (5) patient-reported outcomes (PROs), (6) complications (including recurrent instability), (7) patient satisfaction, and (8) return to preinjury level of activity or sport. Variability in outcome measures was then qualitatively assessed.
RESULTS: Sixty-eight studies were included for final analysis ranging from Level I to IV evidence. Fifty-nine percent reported ROM, and 18% measured strength. Other clinical exam maneuvers were assessed in 44%, with 40% assessing apprehension. Imaging was used in 62%, including X-rays, magnetic resonance imaging, and computed tomography scans. On average, 2.25 PROs were assessed. In total, 28 different PROs were used to assess outcomes. The 3 most commonly reported PROs were the Rowe scale at 46%, the Western Ontario Shoulder Instability Index at 31%, and the Constant Shoulder Score at 26%. Twenty-five percent included patient satisfaction in their assessment of outcomes. Recurrence was assessed by 59%, and return to preinjury level of activity was reported by 37% of the studies.
CONCLUSIONS: There is substantial variability in outcome reporting for high-impact anterior shoulder instability literature with 28 different outcome tools used, making it difficult to compare outcomes between studies. Agreeing upon a uniform measure to assess outcomes would allow for clearer interpretation of the literature as well as the potential to draw conclusions from pooled data. LEVEL OF EVIDENCE: Level IV, systematic review of Level I to IV studies. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27769608     DOI: 10.1016/j.arthro.2016.07.027

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  4 in total

1.  Return to Sports and Recurrences After Arthroscopic Anterior Shoulder Stabilization in Martial Arts Athletes.

Authors:  Maximiliano Ranalletta; Luciano A Rossi; Adrian Sirio; Fernando Diaz Dilernia; Agustin Bertona; Gastón D Maignon; Santiago L Bongiovanni
Journal:  Orthop J Sports Med       Date:  2017-09-13

Review 2.  Variability of Reporting Recurrence After Arthroscopic Bankart Repair: A Call for a Standardized Study Design.

Authors:  Mitchell I Kennedy; Colin Murphy; Grant J Dornan; Gilbert Moatshe; Jorge Chahla; Robert F LaPrade; Matthew T Provencher
Journal:  Orthop J Sports Med       Date:  2019-05-30

3.  Anterior Glenohumeral Instability: Systematic Review of Outcomes Assessment Used in Brazil.

Authors:  Jorge Henrique Assunção; Eduardo Angeli Malavolta; Fernando José de Souza; Mauro Emilio Conforto Gracitelli; Arnaldo Amado Ferreira Neto
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2019-09-23

4.  High Variability in Functional Outcomes and Recurrences Between Contact Sports After Arthroscopic Bankart Repair: A Comparative Study of 351 Patients With a Minimum 3-Year Follow-Up.

Authors:  Luciano Andrés Rossi; Ignacio Tanoira; Tomás Gorodischer; Ignacio Pasqualini; Maximiliano Ranalletta
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.